Quantcast

Latest Cervarix Stories

2008-12-14 10:32:51

British health officials are disputing a mother's claim that a cervical cancer vaccine left her 12-year-old daughter paralyzed from the waist down. Ashleigh Cave, of Aintree, Merseyside, became ill within 30 minutes of receiving the human papillomavirus vaccine, her mother, Cheryl alleged, noting her daughter received the vaccine two months ago and has shown no improvement since. Cave was vaccinated with the drug Cervarix, made by GlaxoSmithKline, as part of a British government-funded...

5d73c28a9a0be312ad3d113de529c95f1
2008-12-03 14:57:00

Australian researchers said on Wednesday that a study of Merck & Co Inc's cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses. The study closely examined 25 Australian girls with suspected hypersensitivity to the vaccine which was administered as part of a national immunization program to all females aged 12 to 26 in the country beginning in 2007. Sharon Choo of the Royal Children's Hospital in Melbourne and...

2008-11-14 00:00:18

A group of U.S. researchers suggests it is premature for states to mandate the human papillomavirus vaccine as a condition for school attendance. The HPV vaccine, sold as Gardasil in the United States, is intended to prevent four strains of HPV, the most common sexually transmitted infection in the world. The vaccine also prevents against cervical cancer. Gail Javitt, Dr. Deena Berkowitz and Lawrence O. Gostin assert that Gardasil is relatively new and long-term safety and effectiveness...

2008-11-06 15:00:06

CINCINNATI, Nov. 6 /PRNewswire/ -- PDS Biotechnology Corporation today announced that the company has been selected as a collaborator of the US National Cancer Institute's Nanotechnology Characterization Lab (NCL) to complete preclinical development of Versamune(TM)-HPV prior to filing of the Investigational New Drug Application. The NCL will perform selected physical, chemical and biological studies on behalf of the company at its facilities at the National Cancer Institute (NCI) in...

2008-11-05 00:00:15

The human papillomavirus, HPV, in cervical as well as head and neck cancers makes them resistant to therapy, U.S. researchers said. Researchers at the University of California, Los Angeles, Jonsson Cancer Center, said virtually all human cancers experience a state called intratumoral hypoxia, or a low amount of oxygen within the tumor. Senior author Dr. Matthew Rettig showed that the HPV-positive cancers adapted to and took advantage of the hypoxic environment by expressing a protein that...

2008-10-17 06:00:06

By Generic For most women, it's a choice whether or not they want Gardasil -- a vaccine that protects against the sexually transmitted human papillomavirus (HPV). Not so for immigrant families with young daughters who are applying for U.S. citizenship. The only choice they have is to either abide by the mandate or give up their American Dream. A 12-year-old immigration law boils down vaccine requirements for green-card applicants to an issue of semantics. Accordingly, vaccines merely...

2008-10-10 21:00:02

One in four teenage girls received at least one dose of a relatively new vaccine against cervical cancer, U.S. health officials said. The 25.1 percent vaccination rate among 13- to 17-year-olds provides the first national estimate of use of Merck & Co.'s Gardasil vaccine, the Centers for Disease Control and Prevention said. Gardasil, administered in a three-dose series, is a vaccine against certain types of human papillomavirus, which infects the skin and mucous membranes. Human...

2008-10-10 18:00:05

ATLANTA - One in four teen girls have rolled up their sleeves for the relatively new vaccine against cervical cancer, federal health officials said Thursday. The figures represent the government's first substantial study of vaccination rates for the Gardasil vaccine - Merck & Co.'s heavily advertised, three-shot series that targets the sexually transmitted human papillomavirus. The vaccine protects against strains of the virus that cause about 70 percent of cervical cancers. Health...

2008-10-09 09:00:52

ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine technology is exclusively licensed from Cedars-Sinai Medical Center. The patent claims are broad and include compositions of peptides for cancer immunotherapy as well as methods for inducing immune responses against tumor antigens in cancer patients. The vaccine being...

2008-09-25 17:46:47

By JAN DISLEY A CATHOLIC school is set to become the first in the country to ban the new cervical cancer jabs. Governors who have already criticised the jabs for "encouraging sexual promiscuity" now say they won't allow pupils to be vaccinated on school grounds. The new jab will be given nationally to girls aged 12 and 13 to protect them against the sexually transmitted papilloma virus, linked to cervical cancer. Experts believe the three injections of the vaccine Cervarix over six...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related